We are pleased to share that we have initiated the RAPHAEL registrational Phase III trial of HMPL-306 in patients with mutated IDH1/2 relapsed/refractory acute myeloid leukemia in China. https://lnkd.in/gKmqqcyB
HUTCHMED’s Post
More Relevant Posts
-
“Every single patient can teach us important lessons”. This landmark paper, published in the NEJM in 2013, highlights several fundamental principles for the management of #CAR_T-cell_therapy and its life-threatening complications through the publication of the very first two cases of children with acute lymphoblastic leukemia treated with this approach. https://lnkd.in/dkM354pz
To view or add a comment, sign in
-
-
Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial https://lnkd.in/euG6HzPz
To view or add a comment, sign in
-
-
Understanding the signs and symptoms of acute lymphoblastic leukemia (ALL) in children is crucial for early detection and treatment. From anemia to swollen lymph nodes, recognizing these indicators can make a significant difference in the journey of young patients battling leukemia. #ALLSeries #LeukemiaChallenges #TreatmentStruggles #SupportNeeded
To view or add a comment, sign in
-
-
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia https://lnkd.in/dRT-h22s
To view or add a comment, sign in
-
-
Oncology Pharmacist @ Burjeel Medical City | ASHP Certified | SIDP Certified | Direct Patient Care | Cancer Research | Clinical Decision Making |
Guidelines for Venetoclax dosing in AML A Systematic Review of Venetoclax and Azacitidine: Effectiveness and Safety for Newly Diagnosed and Relapsed Acute Myeloid Leukemia Patients https://lnkd.in/de8ZVUmZ
To view or add a comment, sign in
-
-
Want to learn more about managing patients with chronic lymphocytic leukemia (CLL)? Watch this new sponsored video on updates in CLL: https://lnkd.in/dPK39eyV #LeukemiaAwareness #CLL
To view or add a comment, sign in
-
-
Did you know why today 9/22 as a world CML day? Around 95% of chronic myelogenous leukemia (CML) patients show DNA "swapped" also called translocation between “chromosomes 9 and 22”. Part of chromosome 9 goes to 22 and part of 22 goes to 9. However, Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician. CML shouldn’t be considered as “good cancer”, let’s remember this meaningful day 9/22 and dedicate to bridge the communication disparity between physicians and CML patients. https://lnkd.in/gA-HFEUg #SUNsurvey #922CMLDAY #WCMLD23 #CureCML #breakthesilence
To view or add a comment, sign in
-
-
Hairy cell leukemia coexistent with chronic lymphocytic leukemia https://lnkd.in/diVfFFXK
To view or add a comment, sign in
-
-
🌟 Encouraging News in Leukemia Research! 🌟 The AML-ViVA trial, funded by the Anticancer Fund, reveals promising outcomes for Acute Myeloid Leukemia (AML) patients above 60 who don't respond to initial chemotherapy. The combination of azacitidine, pioglitazone, and all-trans retinoic acid proves safe and effective. Let's join efforts in spreading awareness for improved treatment options in AML. Read more about this trial: https://lnkd.in/eGr8BNmE #anticancerfund #CancerResearch #acutemyeloidleukemia University Hospital Regensburg Gauthier B.
To view or add a comment, sign in
-
Managing Partner at Globescape Capital Inc.
3moWhich China clinical CRO?